Pediatric thyroid testing issues

Mark D DeBoer1, Stephen H Lafranchi

  • 1Department of Pediatrics, Division of Endocrinology, University of Virginia, VA, USA.

Insights

Pediatric thyroid function tests can be misleading due to various factors. Understanding these complexities is crucial for accurate diagnosis of thyroid disorders in children.

Area of Science:

  • Pediatric Endocrinology
  • Clinical Chemistry
  • Diagnostic Medicine

Background:

  • Thyroid dysfunction is prevalent in pediatric populations.
  • Accurate diagnosis typically relies on serum thyroid function tests.
  • However, certain clinical scenarios can yield inaccurate test results.

Observation:

  • Total thyroxine (T4) levels can be falsely interpreted in cases of thyroid binding globulin (TBG) deficiency or excess.
  • Free thyroxine (FT4) assays may be inaccurate with low or high binding protein levels.
  • Prematurity and non-thyroidal illness (NTI) can mimic central hypothyroidism.
  • Thyroid stimulating hormone (TSH) ranges vary in children and are influenced by medications and NTI.
  • Assays for T4 and TSH can be affected by heterophile antibodies and anti-T4/anti-TSH antibodies.

Findings:

  • Misleading thyroid function test results are common in pediatric patients.
  • Thyroid binding globulin variations and measurement techniques impact T4 accuracy.
  • Prematurity, NTI, and antibody interference complicate TSH and FT4 interpretation.
  • Wider normal TSH ranges in children require careful consideration.

Implications:

  • Clinicians must be aware of factors that can confound thyroid function test interpretation in children.
  • Alternative or confirmatory testing may be necessary in complex pediatric cases.
  • Understanding these interferences is vital for appropriate diagnosis and management of pediatric thyroid disorders.

Related Concept Videos

Hypothyroidism II: Pathophysiology01:23

Hypothyroidism II: Pathophysiology

Hypothyroidism is a disorder characterized by insufficient production of thyroid hormones, which regulate metabolism, energy balance, and multiple organ systems.TypesHypothyroidism is classified based on the level of dysfunction. Primary hypothyroidism results from intrinsic thyroid gland dysfunction, causing reduced hormone production despite normal or increased stimulation. Secondary hypothyroidism arises from inadequate thyroid-stimulating hormone (TSH) secretion by the pituitary. Tertiary...
Hyperthyroidism I: Introduction01:25

Hyperthyroidism I: Introduction

Hyperthyroidism is a type of thyrotoxicosis characterized by the thyroid gland's overproduction of the thyroid hormones triiodothyronine (T3) and thyroxine (T4). This hormone excess increases the basal metabolic rate and enhances sensitivity to catecholamines.DiagnosisDiagnosis is based on clinical features and biochemical testing. It typically shows suppressed thyroid-stimulating hormone (TSH) levels below 0.4 mIU/L, with elevated free T3 and/or T4. Additional tests, including thyroid...
Pharmacokinetics in Pediatric Patients: Overview and Drug Absorption01:23

Pharmacokinetics in Pediatric Patients: Overview and Drug Absorption

Understanding the physiological differences in the pediatric population is crucial for effective pharmacotherapy. Neonates, infants, and children exhibit significant variations in gastric pH, gastric emptying time, intestinal transit time, and biliary function. These variations profoundly affect oral drug absorption, necessitating a nuanced approach to pediatric dosing.Neonates present with a unique physiological profile, having a gastric pH greater than 4 and faster and more irregular gastric...
Hyperthyroidism II: Pathophysiology01:27

Hyperthyroidism II: Pathophysiology

Hyperthyroidism is a hypermetabolic state caused by elevated levels of thyroid hormones, triiodothyronine (T3) and thyroxine (T4). It results from dysregulation at the thyroid, pituitary, or immune system level and affects multiple organ systems.PathophysiologyThe most common cause of hyperthyroidism is Graves’ disease, an autoimmune disorder in which antibodies, specifically thyroid-stimulating antibodies (TSAb), a subtype of TSH receptor antibodies (TRAb), bind to and activate TSH receptors...
Pharmacokinetics in Pediatric Patients: Drug Excretion01:26

Pharmacokinetics in Pediatric Patients: Drug Excretion

In pediatric medicine, understanding the renal function and drug elimination nuances is crucial for administering safe and effective treatments. Newborns, in particular, display markedly slower renal functions than adults, profoundly affecting how drugs are cleared from their bodies. This slower drug clearance requires clinicians to extend the dosing intervals for many medications to prevent drug accumulation and toxicity while ensuring therapeutic efficacy.One key area where these adjustments...
Graves Disease II: Pathophysiology01:24

Graves Disease II: Pathophysiology

Graves’ disease is an autoimmune disorder characterized by the production of thyroid-stimulating immunoglobulins (TSI) that activate TSH receptors, leading to excessive synthesis and release of thyroid hormones (T3 and T4) and resulting in hyperthyroidism.Among all causes of hyperthyroidism, Graves’ disease is the most common and can happen at any age, though it is more frequent in women. It produces a hypermetabolic state with features such as weight loss, tachycardia, tremor, and heat...